FOLD Q3 2017 Earnings — Amicus Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

FOLDAmicus Therapeutics, Inc.

$5B

Q3 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$11M+411.2% YoY

Gross Profit

$9M83.5% margin

Operating Income

-$275M-2531.1% margin

Net Income

-$112M-1026.9% margin

EPS (Diluted)

$-0.69

QoQ Revenue Growth

+51.9%

Cash Flow

Operating Cash Flow

-$50M

Free Cash Flow

-$51M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$681M

Total Liabilities

$271M

Stockholders' Equity

$410M

Cash & Equivalents

$64M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$11M	$2M	+411.2%
Gross Profit	$9M	$2M	+409.5%
Operating Income	-$275M	-$45M	-512.4%
Net Income	-$112M	-$47M	-139.3%